SCHEMBL6176643

SCHEMBL6176643

Cc1cccc([C@@H]2CCCN2S(=O)(=O)c2ccc(F)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.70
GLA P06280 1/20 0.52
PSEN1 P49768 1/20 0.51
PSEN2 P49810 1/20 0.51
APH1B Q8WW43 1/20 0.51
NCSTN Q92542 1/20 0.51
APH1A Q96BI3 1/20 0.51
PSENEN Q9NZ42 1/20 0.51
LMNA P02545 5/20 0.50
MAPT P10636 3/20 0.50
THRB P10828 1/20 0.49
TP53 P04637 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GAA P10253 2/20 0.46
ALDH1A1 P00352 2/20 0.46
USP2 O75604 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176638 1.00 TRPA1 (0.70) TRPA1GLAPSEN1PSEN2APH1B
SCHEMBL3942005 0.96 TRPA1 (0.64) TRPA1GLAPSEN1PSEN2APH1B
SCHEMBL6178952 0.91 TRPA1 (0.56) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178957 0.91 TRPA1 (0.56) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6179258 0.88 PSEN1 (0.67) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6179250 0.88 PSEN1 (0.67) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178548 0.88 TRPA1 (0.70) TRPA1GLAPSEN1PSEN2APH1B
SCHEMBL6178544 0.88 TRPA1 (0.70) TRPA1GLAPSEN1PSEN2APH1B
SCHEMBL6178648 0.88 TRPA1 (0.62) TRPA1GLAPSEN1PSEN2APH1B
SCHEMBL6178650 0.88 TRPA1 (0.62) TRPA1GLAPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed